Current views on the role of human papillomaviruses in cutaneous oncogenesis

International Journal of Dermatology

Volumn 45, Issue 3, 2006, Pages 192-196

  Majewski, Slawomir ^a   Jablonska, Stefania ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERFERON; PROTEIN E6; VIRUS DNA;

CELL PROLIFERATION; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; HEREDITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; ULTRAVIOLET RADIATION; VERRUCA VULGARIS; WART VIRUS;

ANIMALS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DNA, VIRAL; EPIDERMODYSPLASIA VERRUCIFORMIS; HUMANS; KERATINOCYTES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SKIN NEOPLASMS;

EID: 33644790638     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2006.02758.x     Document Type: Review

References (44)

1. Berkhout RJM, Tieben LM, Smits HL, et al. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers. J Clin Microbiol 1995; 33: 690-699.
2. Harwood CA, Spink PJ, Surentheran T, et al. Degenerate and nested PCR: A highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J Clin Microbiol 1999; 37: 3545-3555.
3. Harwood CA, Proby CM. Human papillomaviruses and nonmelanoma skin cancer. Curr Opin Infect Dis 2002; 15: 101-114.
4. Orth G, Jablonska S, Favre M, et al. Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis. Proc Natl Acad Sci USA 1978; 75: 1537-1541.
5. Orth G, Favre M, Majewski S, et al. Epidermodysplasia verruciformis defines a subset of cutaneous papillomaviruses. J Virol 2001; 75: 4952-4953.
6. Shope RE. Infectious papillomatosis of rabbits (with a note on the histopathology by E. W. Hurst). J Exp Med 1933; 58: 607-624.
7. Chan SY, Delius H, Halpern AL, et al. Analysis of genomic sequences of 95 papillomavirus types: Uniting typing, phylogeny, and taxonomy. J Virol 1995; 69: 3074-3083.
8. de Villiers EM, Fauquet C, Broker ThR, et al. Classification of papillomaviruses. Virol 2004; 324: 17-27.
9. Majewski S, Jablonska S. Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 1997; 36: 659-685.
10. Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 1995; 131: 1312-1318.
11. Jablonska S, Orth G, Obalek S, et al. Oncogenic potential of human papillomaviruses epidermodysplasia verruciformis: A counterpart of shope papilloma-carcinoma complex. Arch Geschwulstforsh 1983; 53: 207-215.
12. Orth G. Epidermodysplasia verruciformis a model for understanding the oncogenicity of human papillomaviruses. Ciba Found Symp 1986; 120: 157-174.
13. Zur Hausen H. Papillomavirus infections - A major cause of human cancers. Biochim Biophys Acta 1996; 1288: F55-F78.
14. Zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-350.
15. Ramoz N, Rueda LA, Rueda B, et al. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nature Genet 2002; 32: 579-581.
16. Berkhout RJ, Bouwes Bavnick JN, ter Schegget J. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 2000; 38: 2087-2096.
17. Harwood CA, Spink PJ, Surentheran T, et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent recipients. J Clin Microbiol 2000; 38: 2087-2096.
18. Bouwes Bavinck JN, Feltkarmp M, Struijk L, et al. Human papillomavirus infection and skin cancer risk in organ transplant recipients. J Invest Dermatol Symp Proc 2001; 6: 207-211.
19. Euvrard S, Kanitakis J, Claudy A. Tumeurs cutanees chez les greffes d'organes. Presse Med 2002; 31: 1895-1903.
20. Surentheran T, Harwood CA, Spink PJ, et al. Detection and typing of human papillomaviruses in mucosal and cutaneous biopsies from immunosuppressed and immunocompetent patients and patients with epidermodysplasia verruciformis: Unified diagnostic approach. J Clin Pathol 1998; 51: 606-610.
21. Jensen P, Hansen S, Moller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppresive therapy regimens. J Am Acad Dermatol 1999; 40: 177-186.
22. Naldi L, Fortina AB, Lovati S, et al. Risk of non-melanoma skin cancer in Italian organ transplant recipients: A registry-based study. Transplantation 2000; 70: 1479-1484.
23. Ong CS, Keogh AM, Macdonald PS, et al. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999; 40: 27-34.
24. Pfister H, Fuchs PG, Majewski S, et al. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch Dermatol Res 2003; 295: 273-279.
25. Harwood CA, Surenheran T, Ssasieni P, et al. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 2004; 150: 949-957.
26. Astori G, Lavergne D, Benton C, et al. Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol 1998; 110: 752-755.
27. Antonsson A, Forsulund O, Ekberg H, et al. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol 2000; 74: 11636-11164.
28. Boxman ILA, Mulder LHC, Russell A, et al. Human papillomavirus type 5 is commonly present in immunosuppressed and immunocompetent individuals. Br J Dermatol 1999; 141: 246-249.
29. Cairey-Remonnay S, Humbey O, Mougin Ch, et al. TP53 polymorphism of exon 4 at codon 72 in cutaneous squamous cell carcinoma and benign epithelial lesions of renal transplant recipients and immunocompetent individuals: lock of carcinoma with human papillomavirus status. J Invest Dermatol 2002; 118: 1026-1031.
30. Iftner A, Klug SJ, Garbe C, et al. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors. Cancer Res 2003; 65: 7515-7519.
31. Forslund O, Lindelof B, Hradil E, et al. High prevalence of cutaneous human papillomavirus DNA on the top skin tumors but not in "'stripped" biopsies from the same tumors. J Invest Dermatol 2004; 123: 388-394.
32. Jackson S, Storey A. E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Oncogene 2000; 19: 592-598.
33. Jackson S, Harwood C, Thomas M, Banks L, Storey A. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 2000; 14: 3065-3073.
34. Giampieri S, Garcia-Escudero R, Green J, et al. Human papillomavirus type 77 E6 protein selectively inhibits p53-dependent transcription of proapoptotic genes following UV-B irradiation. Oncogene 2004; 23: 5864-5870.
35. Giampieri S, Storey A. Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from human papillomaviruses types 5 and 18. Br J Cancer 2004; 90: 2203-2209.
36. Iftner T, Elbel M, Schopp B, et al. Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1. EMBO J 2002; 21: 4741-4748.
37. Purdie KJ, Pennington J, Proby CM, et al. The promoter of a novel human papillomavirus (HPV77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence. EMBO J 1999; 18: 5359-5369.
38. Ruhland A, de Villiers EM. Opposite regulation of the HPV 20-URR and HPV 27-URR promoters by ultraviolet irradiation and cytokine. Int J Cancer 2001; 91: 828-834.
39. Antonsson A, Karanfilovska S, Lindqvist PG, et al. General acquisition of human papillomaviruses infections of skin occurs in early infancy. J Clin Microbiol 2003; 41: 2509-2514.
40. de Jong-Tieben LM, Berkhout RJ, ter Schegget J, et al. The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: A clinical study to assess risk factors for keratotic skin lesions and skin cancers. Transplantation 2000; 69: 44-49.
41. Favre M, Majewski S, Noszczyk B, et al. Antibodies to human papillomavirus type 5 are generated in epidermal repair processes. J Invest Dermatol 2000; 114: 403-407.
42. Majewski S, Jablonska S. Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations? Arch Dermatol 2002; 138: 649-654.
43. Favre M, Orth G, Majewski S, et al. Psoriasis: A possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Invest Dermatol 1998; 110: 311-317.
44. Mahé E, Majewski S, Jablonska S, et al. High prevalence of antibodies against HPV5 E6 and E7 oncoproteins in patients with psoriasis. 20th International Papillomavirus Conference. Paris: Institut Pasteur, 2002 October 4-9: 66. Book of Abstracts.